Osteoporosis in Patients with Rheumatoid Arthritis is Associated with Serum Immune Regulatory Cellular Factors

Overview

Journal Clin Rheumatol

Publisher Springer

Specialty Rheumatology

Date 2022 Jun 7

PMID 35670881

Authors

Jianjun Qiu

Chunde Lu

Lei Zhang

Xu Zhou

Hanlin Zou

Affiliations

Soon will be listed here.

Abstract

Objective: Osteoporosis (OP) is a comorbidity of rheumatoid arthritis (RA) that largely causes disability. This study discussed the expression patterns of serum immunoregulatory factors and their clinical significance in RA patients complicated with OP.

Methods: A total of 116 RA patients were enrolled. Bone mineral density (BMD) was measured using dual energy X-ray absorptiometry to allocate patients to OP group (N = 62) and non-OP group (N = 54). CRP, rheumatoid factor, IgG, IgA, and IgM were detected using rate nephelometry. Erythrocyte sedimentation rate (ESR) and bone metabolic indexes were detected using Microsed automatic ESR analyzer and Cobas e601 automated immunoassay systems and reagents. IL-17, IL-6, TNF-α, IL-10, and IL-4 levels were determined using ELISA kit and their prediction values on OP were analyzed using the ROC curve. Influencing factors of OP incidence were analyzed using logistic regression model.

Results: RA patients with OP showed increased age, disease course, tender and swollen joints, ESR, CRP, DAS28 scores, β-CTX, IL-17, IL-6, and TNF-α, and decreased 25(OH)D3, IL-10, and IL-4. DAS28 was positively correlated with IL-17, IL-6, and TNF-α, and negatively correlated with IL-10 and IL-4. DAS28, IL-17, IL-10, and IL-4 were independently correlated with OP in RA patients. The combination of DAS28, IL-17, IL-10, and IL-4 can better predict the incidence of OP complication in RA patients.

Conclusion: IL-17, IL-6, TNF-α, IL-10, and IL-4 were associated with disease activity of RA patients complicated with OP. A combination of DAS28, IL-17, IL-10, and IL-4 might predict OP incidence in RA patients.

Citing Articles

Disclosing the impact of metformin and methotrexate in adjuvant arthritis in female rats: molecular docking and biochemical insights on visfatin.

Mahmoud A, Alfadl E, Ahmed A, Abouelella A, Alshazly O, Mohamed M Naunyn Schmiedebergs Arch Pharmacol. 2025; .

PMID: 39878818 DOI: 10.1007/s00210-025-03823-7.

Is there a role for essential fatty acids in osteoporosis?.

Das U Eur J Clin Nutr. 2024; 78(8):659-662.

PMID: 38840032 DOI: 10.1038/s41430-024-01456-2.

Curcumin Co-Encapsulation Potentiates Anti-Arthritic Efficacy of Meloxicam Biodegradable Nanoparticles in Adjuvant-Induced Arthritis Animal Model.

Aslam B, Hussain A, Faisal M, Sindhu Z, Khan R, A Alhidary I Biomedicines. 2023; 11(10).

PMID: 37893036 PMC: 10604063. DOI: 10.3390/biomedicines11102662.

Combined detection of vitamin D, CRP and TNF-α has high predictive value for osteoporosis in elderly men.

Dong Z, Li M, Zhang Y, Liu H, Cui Y Am J Transl Res. 2023; 15(8):5536-5542.

PMID: 37692933 PMC: 10492047.

Pathogenesis of Extraarticular Manifestations in Rheumatoid Arthritis-A Comprehensive Review.

Mitrovic J, Hrkac S, Tecer J, Golob M, Ljilja Posavec A, Kolar Mitrovic H Biomedicines. 2023; 11(5).

PMID: 37238933 PMC: 10216027. DOI: 10.3390/biomedicines11051262.

References

Guo X, Ji J, Zhang J, Hou X, Fu X, Luo Y . Anti-inflammatory and osteoprotective effects of Chikusetsusaponin Ⅳa on rheumatoid arthritis via the JAK/STAT signaling pathway. Phytomedicine. 2021; 93:153801. DOI: 10.1016/j.phymed.2021.153801. View

Jiang Q, Yang G, Liu Q, Wang S, Cui D . Function and Role of Regulatory T Cells in Rheumatoid Arthritis. Front Immunol. 2021; 12:626193. PMC: 8047316. DOI: 10.3389/fimmu.2021.626193. View

Scherer H, Haupl T, Burmester G . The etiology of rheumatoid arthritis. J Autoimmun. 2020; 110:102400. DOI: 10.1016/j.jaut.2019.102400. View

Dai S, Hsieh W, Chen C, Lu Y, Huang H, Chang D . TDAG8 deficiency reduces satellite glial number and pro-inflammatory macrophage number to relieve rheumatoid arthritis disease severity and chronic pain. J Neuroinflammation. 2020; 17(1):170. PMC: 7257243. DOI: 10.1186/s12974-020-01851-z. View

Casanova-Vallve N, Constantin-Teodosiu D, Filer A, Hardy R, Greenhaff P, Chapman V . Skeletal muscle dysregulation in rheumatoid arthritis: Metabolic and molecular markers in a rodent model and patients. PLoS One. 2020; 15(7):e0235702. PMC: 7340297. DOI: 10.1371/journal.pone.0235702. View

Buttgereit F, Palmowski A . How to taper glucocorticoids in inflammatory rheumatic diseases? A narrative review of novel evidence in rheumatoid arthritis, systemic lupus erythematosus, and giant cell arteritis. Joint Bone Spine. 2021; 89(1):105285. DOI: 10.1016/j.jbspin.2021.105285. View

Emmungil H, Yildiz F, Gozukara M, Acikalin A . Rheumatoid pleural effusion with nodular pleuritis. A rare presentation of rheumatoid arthritis. Z Rheumatol. 2014; 74(1):72-4. DOI: 10.1007/s00393-014-1462-4. View

Gecmen C, Gecmen G, Kahyaoglu M, Ece D, Ozkan B, Karaman O . Pericardial effusion due to cholesterol pericarditis in case of rheumatoid arthritis. Echocardiography. 2016; 33(10):1614-1616. DOI: 10.1111/echo.13279. View

Hewlett S, Almeida C, Ambler N, Blair P, Choy E, Dures E . Group cognitive-behavioural programme to reduce the impact of rheumatoid arthritis fatigue: the RAFT RCT with economic and qualitative evaluations. Health Technol Assess. 2019; 23(57):1-130. PMC: 6815934. DOI: 10.3310/hta23570. View

10.

Li Y, Jiang L, Zhang Z, Li H, Jiang L, Wang L . Clinical characteristics of rheumatoid arthritis patients with peripheral neuropathy and potential related risk factors. Clin Rheumatol. 2019; 38(8):2099-2107. DOI: 10.1007/s10067-019-04521-5. View

11.

Wu D, Cline-Smith A, Shashkova E, Perla A, Katyal A, Aurora R . T-Cell Mediated Inflammation in Postmenopausal Osteoporosis. Front Immunol. 2021; 12:687551. PMC: 8278518. DOI: 10.3389/fimmu.2021.687551. View

12.

Perrier-Cornet J, Omorou A, Fauny M, Loeuille D, Chary-Valckenaere I . Opportunistic screening for osteoporosis using thoraco-abdomino-pelvic CT-scan assessing the vertebral density in rheumatoid arthritis patients. Osteoporos Int. 2019; 30(6):1215-1222. DOI: 10.1007/s00198-019-04931-w. View

13.

Xie J, Li S, Xiao L, Ouyang G, Zheng L, Gu Y . Zoledronic acid ameliorates the effects of secondary osteoporosis in rheumatoid arthritis patients. J Orthop Surg Res. 2019; 14(1):421. PMC: 6902494. DOI: 10.1186/s13018-019-1492-3. View

14.

Gamsjaeger S, Fratzl P, Paschalis E . Interplay between mineral crystallinity and mineral accumulation in health and postmenopausal osteoporosis. Acta Biomater. 2021; 124:374-381. DOI: 10.1016/j.actbio.2021.02.011. View

15.

Guler-Yuksel M, Bijsterbosch J, Goekoop-Ruiterman Y, de Vries-Bouwstra J, Ronday H, Peeters A . Bone mineral density in patients with recently diagnosed, active rheumatoid arthritis. Ann Rheum Dis. 2007; 66(11):1508-12. PMC: 2111640. DOI: 10.1136/ard.2007.070839. View

16.

Sinigaglia L, Nervetti A, Mela Q, Bianchi G, del Puente A, Di Munno O . A multicenter cross sectional study on bone mineral density in rheumatoid arthritis. Italian Study Group on Bone Mass in Rheumatoid Arthritis. J Rheumatol. 2000; 27(11):2582-9. View

17.

Abdel Meguid M, Hamad Y, Swilam R, Barakat M . Relation of interleukin-6 in rheumatoid arthritis patients to systemic bone loss and structural bone damage. Rheumatol Int. 2012; 33(3):697-703. DOI: 10.1007/s00296-012-2375-7. View

18.

Suh C, Yoo D, Kasay A, Chalouhi El-Khouri E, Cons Molina F, Shesternya P . Long-Term Efficacy and Safety of Biosimilar CT-P10 Versus Innovator Rituximab in Rheumatoid Arthritis: 48-Week Results from a Randomized Phase III Trial. BioDrugs. 2019; 33(1):79-91. PMC: 6373391. DOI: 10.1007/s40259-018-00331-4. View

19.

Yoo D, Suh C, Shim S, Jeka S, Molina F, Hrycaj P . Efficacy, Safety and Pharmacokinetics of Up to Two Courses of the Rituximab Biosimilar CT-P10 Versus Innovator Rituximab in Patients with Rheumatoid Arthritis: Results up to Week 72 of a Phase I Randomized Controlled Trial. BioDrugs. 2017; 31(4):357-367. PMC: 5548818. DOI: 10.1007/s40259-017-0232-7. View

20.

Danks L, Sabokbar A, Gundle R, Athanasou N . Synovial macrophage-osteoclast differentiation in inflammatory arthritis. Ann Rheum Dis. 2002; 61(10):916-21. PMC: 1753924. DOI: 10.1136/ard.61.10.916. View